Small-sized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation (Q38505471)

3 September 2017

title

Small-sized liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation (English)

1 reference

3 September 2017

main subject

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

Hwang S

1

1 reference

3 September 2017

Lee SG

2

1 reference

3 September 2017

Ahn CS

3

1 reference

3 September 2017

Kim KH

4

1 reference

3 September 2017

Moon DB

5

1 reference

3 September 2017

Ha TY

6

1 reference

3 September 2017

Park KM

7

1 reference

3 September 2017

Song GW

8

1 reference

3 September 2017

Jung DH

9

1 reference

3 September 2017

Kim BS

10

1 reference

3 September 2017

Moon KM

11

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Transplantation Proceedings

3 September 2017

published in

1 reference

3 September 2017

volume

39

1 reference

3 September 2017

issue

5

1 reference

3 September 2017

page(s)

1526-1529

1 reference

Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

The role of living-donor liver transplantation in surgical treatment for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Living donor liver transplantation for hepatocellular carcinoma: A single-center preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Regeneration of graft liver in adult-to-adult living donor liver transplantation using a left lobe graft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Donor outcome and liver regeneration after right-lobe graft donation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Hepatocyte growth-factor-scatter factor can stimulate post-operative tumor-cell proliferation in childhood hepatoblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Adult-to-adult living donor liver transplantation at the Asan Medical Center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Clinicopathological features of incidental hepatocellular carcinoma in liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2007.03.066

10.1016/J.TRANSPROCEED.2007.03.066

7 January 2021

Identifiers

DOI

1 reference

3 September 2017

1 reference